| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 13.72B | 13.43B | 15.29B | 16.21B | 14.36B | 12.65B |
| Gross Profit | 2.00B | 2.10B | 2.65B | 2.70B | 1.97B | 1.77B |
| EBITDA | 1.27B | 1.42B | 1.50B | 1.26B | 992.00M | 837.00M |
| Net Income | 1.42B | 286.00M | 349.00M | 218.00M | 147.00M | 52.00M |
Balance Sheet | ||||||
| Total Assets | 18.05B | 18.88B | 19.44B | 18.39B | 16.01B | 16.56B |
| Cash, Cash Equivalents and Short-Term Investments | 3.58B | 2.95B | 3.48B | 2.64B | 2.23B | 780.00M |
| Total Debt | 5.13B | 6.06B | 6.37B | 5.93B | 4.43B | 5.79B |
| Total Liabilities | 14.04B | 16.04B | 16.67B | 15.99B | 13.62B | 14.25B |
| Stockholders Equity | 3.95B | 2.77B | 2.70B | 2.35B | 2.35B | 2.29B |
Cash Flow | ||||||
| Free Cash Flow | 778.00M | 849.00M | 248.00M | 366.00M | 630.00M | -25.00M |
| Operating Cash Flow | 1.03B | 1.11B | 1.20B | 1.34B | 1.41B | 539.00M |
| Investing Cash Flow | 679.00M | -655.00M | -284.00M | -2.22B | -1.34B | -45.00M |
| Financing Cash Flow | -759.00M | -629.00M | 68.00M | 1.49B | 1.34B | -88.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | €4.75B | 15.83 | 42.37% | 2.73% | 12.34% | 23.90% | |
70 Outperform | €4.80B | 1.09 | ― | 1.76% | -8.23% | 285.81% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
60 Neutral | €5.50B | 16.05 | ― | 3.23% | ― | ― | |
59 Neutral | €3.59B | 33.76 | 10.16% | 0.72% | 0.97% | -3.22% | |
56 Neutral | €3.97B | 17.13 | 14.30% | ― | 12.19% | 177.33% | |
50 Neutral | €2.60B | 6.39 | 15.02% | 2.32% | 14.59% | 23.80% |